Specialists

Monica Maria Lopera Calderon

Retina and Vitreous Ophthalmologist / Office 507 - 508

Specialty

Retina and vitreous

Education

Undergraduate: Universidad CES

Specialization: Hospital Rodolfo Robles - Guatemala

Subspecialization: Rodolfo Robles Hospital - Guatemala

Publications:

OCT CHARACTERISTICS OF TRAUMATIC HOLES. Arevalo JF, Sanchez JG, Costa RA, Farah ME, Berrocal MH, Graue-Wiechers F, Lizana C, Robledo V, Lopera M. Eye. 2007 Sep 7

Member of:

    • Colombian Society of Ophthalmology
    • < li>
Acorev (Colombian Association of Retina and Vitreous)
  • Research group of the Sandiego Ophthalmology Clinic
< h3>Research experience:
  1. Principal Investigator of the gather study Phase 3 multicenter, randomized, double-blind, sham-controlled clinical trial to assess safety and the efficacy of intravitreal administration of zimura tm (c5 complement inhibitor) in patients with geographic atrophy secondary to dry age-related macular degeneration.
     
  2. Principal investigator of the longitudinal biomarker study of anti-vegf to explore the relationship between aqueous humor composition and retinal multimodal imaging in age-related neovascular macular degeneration and diabetic macular edema.
  3. Open-blind investigator Clinical Study Panda KHB- 1801 to evaluate the efficacy and safety of intravitreal injection of Conbercept in subjects with neovascular age-related macular degeneration (AMD). November 2019 and continues to date.

  4. Open investigator Clinical Study Kestrel RTH258B-2301 to determine the efficacy and safety of brolucizumab versus aflibercept in the treatment of diabetic macular edema. May 2019 and continues to date.

  5. Investigator in the ALLERGAN ARTEMIS Study to determine the efficacy and safety of BRIMATOPROST SR in patients with Ocular Hypertension and Open Angle Glaucoma. 2016 and continues to date.

  6. Open Investigator Alcon Clinical Study RTH258-C001 – HAWK. Efficacy and Safety of RTH258 versus Aflibercept in patients with age-related Neovascular Macular Degeneration. February 2016 to 2018.

  7. Investigator of Ophthotech Clinical Study OPH1004. Use of Fovista in combination with Avastin or Eylea compared with Avastin or Eylea monotherapy in patients with subfoveal neovascular macular degeneration. February 2016 to September 2017.

  8. Investigator of Ophthotech Clinical Study OPH1003. Intravitreal Fovista Combined With Lucentis Versus Lucentis Monotherapy For Patients With Age-Related Macular Degeneration With Subfoveal Neovascularization. June 2014 to January 2015.

  9. Investigator of Study C-12-071 of Alcon. Efficacy and safety of Nepafenac 0.3% once daily in diabetic patients undergoing cataract surgery. April 2014 to January 2015.

  10. Investigator of the Bayer Clinical Study. Use of the drug VEGF Trap in patients with wet Age-Related Macular Degeneration. April 2009 to November 2011 (VIEW2)

  11. Incidence of Retinopathy of Prematurity at the General Hospital of Medellín, Perinatology Service, 1994

Contact

Mail: mlopera69@gmail.com

Phone:(604) 5899611.   (604) 2626363 

Cell: 573053099795

Conoce más de nuestros especialistas

 Alvaro Jose Jaramillo Estrada

Alvaro Jose Jaramillo Estrada

Corneologist - Office: 414

Telephone: 604 2626745 - 604 4085195

Instagram: Dralvarojaramillo

http://alvarojaramillo.co

Entities served: 

Coomeva Prepaid Medicine - Suramericana Policy

 Ana Isabel Rivera Gomez

Ana Isabel Rivera Gomez

Corneologist - Office 709

Mail: airoftalmologa@gmail.com

Phone: 6042626654

Cell: 3106010604

Entities served:

Sura -Coomeva Prepaid - Allianz - Colpatria -Seguros Bolivar - Colmedica - Complementary Plan Sura - EMI

 Alvaro Echeverri Bustamante

Alvaro Echeverri Bustamante

Ophthalmologist / Office 525

Mail: aleb205@gmail.com

Cell: 3152107788

Entities served:

Poliza Sura - Coomeva - Colsanitas - Colmedica -Liberty- Mapfre